Long-Term Follow-Up of Combination of Anti–B-Cell Maturation Antigen and Anti–CD19 CAR T Cells in Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma
J. Clin. Oncol 2022 Mar 25;[EPub Ahead of Print], Y Wang, J Cao, W Gu, M Shi, J Lan, Z Yan, L Jin, J Xia, S Ma, Y Liu, H Li, B Pan, W Chen, X Fei, C Wang, X Xie, L Yu, G Wang, H Li, G Jing, H Cheng, F Zhu, H Sun, W Sang, D Li, Z Li, J Zheng, K XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.